Home > Healthcare > Pharmaceuticals > Finished Drug Form > Injectable Contraceptives Market

Injectable Contraceptives Market Share

Report ID: GMI6602
Published Date: Aug 2023
Report Format: PDF

Download Free Sample

Injectable Contraceptives Market Share

The prominent players in injectable contraceptives market are

Pfizer Inc.
Amphastar Pharmaeceutical Inc.
Zhejiang xianju Pharmaceutical co., ltd.
Eugia pharma
Mylan labs ltd.
Bayer Plc
Teva Pharms USA
PT Tunggal
Incepta Pharmaceuticals
Baxter International Inc.

These companies are implementing several strategies such as collaborations, acquisitions, partnerships, mergers, and product launches to maintain a competitive edge in the industry.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Injectable contraceptives industry size was valued at USD 339.5 million in 2022 and will register 3.5% CAGR from 2023-2032 due to the growing awareness about family planning worldwide.

The progesterone-only type segment recorded 68.8% share of the injectable contraceptives industry in 2022 and will witness significant growth from 2023-2032 on account of its high level of efficacy and reliability in preventing unintended pregnancies.

North America injectable contraceptives market size recorded USD 137.3 million in 2022 and is expected to reach USD 186.9 million by 2032 owing to the well-established healthcare systems and widespread access to variety of contraceptives in the region.

Pfizer Inc., Amphastar Pharmaeceutical Inc., Zhejiang xianju Pharmaceutical co., ltd., Eugia pharma, Mylan labs ltd.,Bayer Plc, Teva Pharms USA, PT Tunggal, Incepta Pharmaceuticals, and Baxter International Inc. are some of the major injectable contraceptives companies worldwide.